Jack Jones, MD
Interventional Cardiology · Topeka, KSNPI 1811934896
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $2,008 of the $3,092 with a category attached, or 64.9%. 8 manufacturers reported payments, led by Boston Scientific at 44.9% of the total. Reporting peaked in 2023 at $1,440 and has fallen 92.4% since, to $109 in 2025. That places this record below the midpoint for interventional cardiology clinicians in KS, where the typical reported total is $8,846.
Across 32 payments — averaging $96.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$1K
- W. L. Gore & Associates, Inc.$1K
- Medtronic$161
- Shockwave Medical, Inc$109
- Edwards Lifesciences$51
- Abiomed$45
- plus $43 from 2 others
What the payments were for
- Travel & lodging$2,00865%
- Food & beverage$1,08435%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 16 | $1,388 |
| W. L. Gore & Associates, Inc. | 7 | $1,296 |
| Medtronic(2 entities) | 4 | $161 |
| Shockwave Medical, Inc | 1 | $109 |
| Edwards Lifesciences | 1 | $51 |
| Abiomed | 1 | $45 |
| Abbott | 1 | $23 |
| Cook Medical LLC | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,092 in reported general payments places this provider in the 20th percentile of 55 interventional cardiology providers in Kansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 37 | $34,147 |
| Repatha SureclickEvolocumab | 32 | $25,186 |
| Ranolazine ErRanolazine | 20 | $3,103 |
| ClopidogrelClopidogrel Bisulfate | 262 | $2,645 |
| Atorvastatin Calcium | 224 | $2,226 |
| Metoprolol Succinate | 114 | $1,981 |
| Ezetimibe | 30 | $1,008 |
| Isosorbide Mononitrate ErIsosorbide Mononitrate | 86 | $1,000 |
| Amlodipine Besylate | 134 | $793 |
| Carvedilol | 95 | $765 |
| FenofibrateFenofibrate Nanocrystallized | 13 | $733 |
| Cilostazol | 39 | $721 |
| Metoprolol Tartrate | 125 | $591 |
| Rosuvastatin Calcium | 67 | $577 |
| Lisinopril | 89 | $558 |
Paid to pharmacies, not to this prescriber.
Other interventional cardiology in Topeka
- Ahmed SoukaTopeka$37K
- Sindhu AvulaTopeka$18K
- Seshu RaoTopeka$6K
- Bashar AbabnehTopeka$2K
- Anthony SpaedyKansas City$385K
- Prasad GunasekaranKansas City$76K
- Maheedhar GedelaWichita$54K
- Kamal GuptaKansas City$46K
- Priyantha RanaweeraManhattan$41K
- Mark WileyKansas City$39K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.